Recursion (RXRX) analyst forecast and price target
Analyst forecast
Consensus of 7 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Equal-Weight | $5.50 from $5.00 | May 14, 2026 |
| Needham | Maintained | Buy | $8.00 | May 7, 2026 |
| JP Morgan | Maintained | Overweight | $10.00 from $11.00 | Apr 30, 2026 |
| Needham | Maintained | Buy | $8.00 | Feb 26, 2026 |
| B of A Securities | Maintained | Neutral | $6.00 from $7.00 | Feb 26, 2026 |
| JP Morgan | Upgraded | Neutral → Overweight | $11.00 from $10.00 | Dec 17, 2025 |
| Needham | Maintained | Buy | $8.00 | Sep 11, 2025 |
| Needham | Maintained | Buy | $8.00 | Jul 8, 2025 |
| Morgan Stanley | Initiated Coverage | Equal-Weight | $5.00 | Jul 3, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $5.00 from $8.00 | Jun 16, 2025 |
| Needham | Maintained | Buy | $8.00 from $11.00 | May 6, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $8.00 from $10.00 | Apr 10, 2025 |
| Needham | Maintained | Buy | $11.00 | Apr 8, 2025 |
| Leerink Partners | Maintained | Market Perform | $6.00 from $7.00 | Feb 28, 2025 |
| Needham | Maintained | Buy | $11.00 | Feb 6, 2025 |
| Keybanc | Maintained | Overweight | $10.00 from $12.00 | Jan 8, 2025 |
| Needham | Maintained | Buy | $11.00 | Dec 11, 2024 |
| Needham | Maintained | Buy | $11.00 | Nov 20, 2024 |
| Needham | Maintained | Buy | $11.00 | Nov 7, 2024 |
| Needham | Maintained | Buy | $11.00 from $16.00 | Sep 4, 2024 |
Frequently asked questions
Is RXRX a buy, sell, or hold?
Analysts covering Recursion currently average a Hold rating: 3 buy, 4 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on RXRX?
On May 14, 2026, Morgan Stanley maintained Recursion at Equal-Weight with a price target of $5.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.